Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Catheter Precision, Inc. Director's Dealing 2021

Feb 6, 2021

35479_dirs_2021-02-05_ced89885-e0fb-40ab-ae1b-3d1c49fe3645.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Ra Medical Systems, Inc. (RMED)
CIK: 0001716621
Period of Report: 2021-01-31

Reporting Person: Meline Susanne (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1808 Direct
Common Stock 40000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrants (right to buy) $11.25 2025-05-22 Common Stock (88888) Indirect
Warrants (right to buy) $8.75 2025-08-03 Common Stock (68571) Indirect

Footnotes

F1: Securities are owned by Catalysis Partners ("CP"). The reporting person has an investment interest in CP through her IRA and, together with an immediate family member, owns a controlling interest in Francis Capital Management, LLC, which also has an investment interest in CP and serves as both its Managing Member and Investment Manager. The reporting person disclaims beneficial interest of these securities except to the extent of her pecuniary interest therein.